Addressing Sex and Gender Disparities in Cardiovascular Health
A European Call to Action
Summary
Cardiovascular disease is the leading cause of death among European women, with a mortality rate of 37% compared to 31% in men, yet structural heart disease in women remains under-researched, under-diagnosed and under-treated.
Women are less likely to receive routine cardiac exams at GP visits (24.2% vs. 31.3% for men), are 50% more likely than men to be initially misdiagnosed, and can wait an average of 7 months longer from symptoms to treatment.
The Task Force on Women’s Heart Health calls on EU and national policymakers, healthcare systems and researchers to close the gap in SHD care for women.
Our recommendations
Prioritizing sex and gender-specific initiatives in the EU Cardiovascular Plan
Dedicated funding for research and programmes on women’s heart health, especially early detection and treatment of SHD.
Promote public awareness campaigns
Public health campaigns on women’s specific cardiovascular risks and the value of early detection and symptom recognition.
Mandate sex and gender-sensitive research
Legislation requiring women to be proportionally represented in clinical trials, and funding targeted at sex- and gender-related differences in SHD.
Support early detection programs
Routine screening for women, particularly those aged 55 and over and at key life stages, with AI diagnostic tools considered.
Secure dedicated funding for SHD treatment access
National funding for SHD treatments for women and removal of cost barriers, especially for older and socioeconomically disadvantaged women.